학술논문

A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
Document Type
article
Source
Communications Biology, Vol 5, Iss 1, Pp 1-12 (2022)
Subject
Biology (General)
QH301-705.5
Language
English
ISSN
2399-3642
Abstract
A proof-of-concept study on the genomic evolution of SARS-CoV-2 during antiviral treatment reveals that Molnupiravir induces a higher in vivo intra-host variability compared to Paxlovid and drug-naive.